Tag: David Wilson
GSK to acquire Chimagen asset in deal worth up to USD750m
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million
English
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million
India’s 2026 model BIT must align investment protection with climate obligations for long-term treaty coherence